Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Lippens

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Biomarker Research|April 14, 2025
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemiaArnaud Métois, Marie-Eve Bordeleau, Louis Theret, et al.
Antibody Therapeutics|September 24, 2025
Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cellsScott McComb, Bianca Dupont, Alex Shepherd, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Biomarker Research|April 14, 2025
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemiaArnaud Métois, Marie-Eve Bordeleau, Louis Theret, et al.
Antibody Therapeutics|September 24, 2025
Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cellsScott McComb, Bianca Dupont, Alex Shepherd, et al.
Pageof 2